Article
PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma: A Multi-institutional Study.
The American journal of surgical pathology - 1 Oct 2024
Agarwal Shipra, Jung Chan Kwon, Gaddam Pranitha, Hirokawa Mitsuyoshi, Higashiyama Takuya, Hang Jen-Fan, Lai Wei-An, Keelawat Somboon, Liu Zhiyan, Na Hee Young, Park So Yeon, Fukuoka Junya, Satoh Shinya, Mussazhanova Zhanna, Nakashima Masahiro, Kakudo Kennichi, Bychkov Andrey
Abstract excerpt
Anti-PD immunotherapy is currently under investigation in anaplastic thyroid carcinoma (ATC). Tumor cell surface PD-L1 expression is considered predictive of therapeutic response. Although papillary thyroid carcinoma has been widely studied for PD-L1 expression, there are limited data on ATC. In this retrospective multi-institutional study involving 9 centers across Asia, 179 ATCs were assessed for PD-L1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
